Skip to content

Pharmacy

NCPA turns spotlight on underpayment for generics

NCPA turns spotlight on underpayment for generics

The National Community Pharmacists Association said it has compiled evidence that underscores the need for federal sunshine legislation to provide more insight into below-cost reimbursements from pharmacy benefit managers that don’t keep pace with rising market costs for generic drugs.

Galderma set to launch Epiduo Forte Gel

Galderma set to launch Epiduo Forte Gel

Galderma Laboratories has received Food and Drug Administration approval for antibiotic-free Epiduo Forte Gel (adapalene and benzoyl peroxide 0.3%/2.5%), a once-daily topical acne treatment. Galderma said Thursday Epiduo Forte Gel is the first combination of 0.3%/2.

National Rx program sought in Canada

National Rx program sought in Canada

launched in late June by the Canadian Pharmacists Association (CPhA) — aims to build a national consensus for a pan-Canadian pharmacare framework. CPhA noted that all developed countries with universal health care, except Canada, provide universal coverage for

Competition escalates in retail clinic arena

Competition escalates in retail clinic arena

The retail health clinic market is seeing competition intensify as the leading players expand their reach with new locations. Market leader MinuteClinic, part of CVS Health, got a big boost last month with CVS’ $1.9 billion deal to buy the pharmacy and clinic business of Target Corp.

NACDS hails House passage of 21st Century Cures

NACDS hails House passage of 21st Century Cures

The U.S. House of Representatives has passed the 21st Century Cures Act (H.R. 6), which the National Association of Chain Drug Stores said will speed the pace of cures and medical breakthroughs and position pharmacy to play a pivotal role in the delivery of new drug treatments to patients.

Novartis set to release Entresto heart failure drug

Novartis set to release Entresto heart failure drug

Novartis has received Food and Drug Administration approval for Entresto (sacubitril/valsartan) tablets, a medication for heart failure with reduced injection fraction. An angiotensin receptor neprilysin inhibitor (ARNI), Entresto reduces the strain on a failing heart.

Small chains show they can compete

Small chains show they can compete

Walgreens, CVS/Pharmacy, Rite Aid and Walmart among them — receive a great deal of attention. Similarly, regional chains including Wegmans, H-E-B, Publix and Schnucks are examples of a force in their respective markets.